655 related articles for article (PubMed ID: 18937733)
21. Transfusion-related acute lung injury (TRALI) in graft by blood donor antibodies against host leukocytes.
Goodwin J; Tinckam K; denHollander N; Haroon A; Keshavjee S; Cserti-Gazdewich CM
J Heart Lung Transplant; 2010 Sep; 29(9):1067-70. PubMed ID: 20627626
[TBL] [Abstract][Full Text] [Related]
22. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
Sachs UJ; Kauschat D; Bein G
Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
[TBL] [Abstract][Full Text] [Related]
23. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
Nicolle AL; Chapman CE; Carter V; Wallis JP
Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
[TBL] [Abstract][Full Text] [Related]
24. [Transfusion-related acute lung injury with anti-leukocyte antibodies identified both in patient's serum and in red cell concentrate].
Nishizawa M; Hirayama F; Matsuyama N; Tada K; Kaneko H; Watanabe M; Miura Y; Tsudo M
Rinsho Ketsueki; 2009 Jan; 50(1):16-22. PubMed ID: 19225224
[TBL] [Abstract][Full Text] [Related]
25. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
[TBL] [Abstract][Full Text] [Related]
26. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration.
Danielson C; Benjamin RJ; Mangano MM; Mills CJ; Waxman DA
Transfusion; 2008 Nov; 48(11):2401-8. PubMed ID: 18673344
[TBL] [Abstract][Full Text] [Related]
28. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.
Ozier Y; Muller JY; Mertes PM; Renaudier P; Aguilon P; Canivet N; Fabrigli P; Rebibo D; Tazerout M; Trophilme C; Willaert B; Caldani C
Transfusion; 2011 Oct; 51(10):2102-10. PubMed ID: 21382042
[TBL] [Abstract][Full Text] [Related]
29. Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study.
Middelburg RA; van Stein D; Atsma F; Wiersum-Osselton JC; Porcelijn L; Beckers EA; Briët E; van der Bom JG
Transfusion; 2011 Oct; 51(10):2111-7. PubMed ID: 21985044
[TBL] [Abstract][Full Text] [Related]
30. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
31. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
[TBL] [Abstract][Full Text] [Related]
32. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
Porretti L; Coluccio E; Prati D; Colombo MB; Lopa R; Tombolini P; Ambrosone A; Crespiatico L; Scalamogna M; Rebulla P
Eur J Haematol; 2004 Oct; 73(4):295-9. PubMed ID: 15347317
[TBL] [Abstract][Full Text] [Related]
33. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
Flesch BK; Petershofen EK; Bux J
Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
[TBL] [Abstract][Full Text] [Related]
34. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
35. Transfusion-related acute lung injury (TRALI): a review of investigations by the National Tissue Typing Laboratory of cases reported in New Zealand since June 2004.
Dunn P; Dinesh D
N Z Med J; 2008 Jun; 121(1276):42-7. PubMed ID: 18574508
[TBL] [Abstract][Full Text] [Related]
36. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
Nakagawa M; Toy P
Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
[TBL] [Abstract][Full Text] [Related]
37. Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.
Middelburg RA; Beckers EA; Porcelijn L; Lardy N; Wiersum-Osselton JC; Schipperus MR; Vrielink H; Briët E; van der Bom JG
Transfus Med; 2012 Apr; 22(2):128-32. PubMed ID: 22380759
[TBL] [Abstract][Full Text] [Related]
38. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
39. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
[TBL] [Abstract][Full Text] [Related]
40. Residual plasma in red blood cells and transfusion-related acute lung injury.
Weber LL; Roberts LD; Sweeney JD
Transfusion; 2014 Oct; 54(10):2425-30. PubMed ID: 24762170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
